Clinical Trial

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Name: Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata — clinical trial record (NCT07133308)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-13.

Trial Details

NCT Number	NCT07133308
Lead Sponsor	Sun Pharmaceutical Industries, Inc.
Conditions	Alopecia Areata
Enrollment	355 participants
Start Date	2025-08-05
Primary Completion	2028-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-28